Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caryn A Libbey, M.D.

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Amyloidosis820117950.240 Why?
Gout220205730.230 Why?
Gout Suppressants220201660.190 Why?
Uricosuric Agents12020280.190 Why?
Tattooing12000580.180 Why?
Arthritis120236590.150 Why?
Peripheral Nervous System Diseases120236850.150 Why?
Vasculitis120005190.140 Why?
Rheumatology120205760.120 Why?
Immunoglobulin Light Chains120112770.090 Why?
Colchicine320202430.090 Why?
Stem Cell Transplantation2201116200.080 Why?
Melphalan220044310.080 Why?
Prealbumin219852100.070 Why?
Polyneuropathies119841370.050 Why?
Naltrexone120233070.050 Why?
Hepatitis C Antigens12000340.050 Why?
Hepatitis B Core Antigens12000920.050 Why?
Cryoglobulinemia12000870.040 Why?
Blood Sedimentation120002310.040 Why?
Allopurinol120201910.040 Why?
Aspartate Aminotransferases120004180.040 Why?
Alanine Transaminase120005920.040 Why?
Abdomen1198311180.040 Why?
Fatigue1202315310.030 Why?
Transplantation, Autologous2201121240.030 Why?
Antineoplastic Agents, Alkylating119966270.030 Why?
Biopsy2200067560.030 Why?
Kidney Diseases1198221490.020 Why?
Adipose Tissue1198332790.020 Why?
Prednisone1199615740.020 Why?
Anti-Inflammatory Agents, Non-Steroidal1202022820.020 Why?
Pilot Projects1202383240.020 Why?
Disease Management1202024590.020 Why?
Double-Blind Method12023120260.020 Why?
Skin1200043640.020 Why?
Anti-Inflammatory Agents1199617900.020 Why?
Texas119843920.010 Why?
England119845220.010 Why?
Humans1220237443430.010 Why?
Quality of Life12023128040.010 Why?
Germany119848620.010 Why?
Combined Modality Therapy1201186420.010 Why?
Staining and Labeling1198311000.010 Why?
Dose-Response Relationship, Drug12011109430.010 Why?
Treatment Outcome22023631140.010 Why?
Biopsy, Needle1198316410.010 Why?
Survival Analysis22004102520.010 Why?
Survival Rate12011127880.010 Why?
Pedigree1198446440.010 Why?
Middle Aged520042133830.010 Why?
Female620043801940.010 Why?
United States12020698720.010 Why?
Longitudinal Studies12004139890.000 Why?
Kidney1198271860.000 Why?
Age Factors11984183700.000 Why?
Drug Therapy, Combination1199664890.000 Why?
Cause of Death1199635840.000 Why?
Retinol-Binding Proteins11985650.000 Why?
Time Factors21987400750.000 Why?
Serum Amyloid A Protein119851210.000 Why?
Risk2198796870.000 Why?
Aged220041632800.000 Why?
Male420043501180.000 Why?
Life Expectancy1198711840.000 Why?
Adolescent11982857810.000 Why?
Sex Factors11987103970.000 Why?
Prognosis11987290630.000 Why?
Libbey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.